View in EDS HTML Full Text PDF Full Text

Tau pathology reduction with SM07883, a novel, potent, and selective oral DYRK1A inhibitor: A potential therapeutic for Alzheimer's disease.

Saved in:
Bibliographic Details
Title: Tau pathology reduction with SM07883, a novel, potent, and selective oral DYRK1A inhibitor: A potential therapeutic for Alzheimer's disease.
Authors: Melchior, Benoît1 (AUTHOR) benoit@samumed.com, Mittapalli, Gopi Kumar1 (AUTHOR), Lai, Carolyn1 (AUTHOR), Duong‐Polk, Karen1 (AUTHOR), Stewart, Joshua1 (AUTHOR), Güner, Bora1 (AUTHOR), Hofilena, Brian1 (AUTHOR), Tjitro, Amanda1 (AUTHOR), Anderson, Scott D.1 (AUTHOR), Herman, David S.1 (AUTHOR), Dellamary, Luis1 (AUTHOR), Swearingen, Christopher J.1 (AUTHOR), Sunil, K.C.1 (AUTHOR), Yazici, Yusuf1 (AUTHOR)
Source: Aging Cell. Oct2019, Vol. 18 Issue 5, pN.PAG-N.PAG. 1p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:14749718
DOI:10.1111/acel.13000